1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL CLINICAL RESEARCH SERVICES MARKET BY SERVICE TYPE
5.1. Introduction
5.2. Clinical Trial Management Services
5.3. Clinical Data Management Services
5.4. Regulatory Services
5.5. Clinical Monitoring Services
5.6. Quality Management Services
5.7. Bioanalytical Services
5.8. Others
6. GLOBAL CLINICAL RESEARCH SERVICES MARKET BY THERAPEUTIC AREA
6.1. Introduction
6.2. Oncology
6.3. Cardiovascular Diseases
6.4. Infectious Diseases
6.5. Neurology
6.6. Respiratory Diseases
6.7. Others
7. GLOBAL CLINICAL RESEARCH SERVICES MARKET BY END-USER
7.1. Introduction
7.2. Pharmaceutical And Biotechnology Companies
7.3. Contract Research Organizations (Cros)
7.4. Academic And Research Institutions
7.5. Others
8. GLOBAL CLINICAL RESEARCH SERVICES MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Iqvia Holdings Inc.
10.2. Pharmaceutical Product Development, Llc (Ppd)
10.3. Parexel International Corporation
10.4. Charles River Laboratories International, Inc.
10.5. Covance Inc. (A Subsidiary Of Laboratory Corporation Of America Holdings)
10.6. Syneos Health Inc.
10.7. Medpace Holdings, Inc.
10.8. Wuxi Apptec Inc.
10.9. Icon Plc
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES